我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
148
6 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1968
已完成
63
42.6%
尚未招募
6
4.0%
招募中
76
51.4%
暂停
1
0.7%
Unknown
2
1.4%
暂无批准数据
- Japanese researchers demonstrate that local injections of adipose-derived mesenchymal stem cells effectively reduce inflammation in ocular graft-versus-host disease, offering a safer alternative to corticosteroids. - The study reveals that stem cell treatment increases regulatory T cells and enhances tissue healing, with injected cells naturally clearing within a week, minimizing long-term complications. - Researchers at Fujita Health University report successful localized therapy effects in mouse models, setting the stage for potential human clinical trials of this targeted treatment approach.
